-- India's Biocon to buy GE Capital stake in research services arm for $35 mln
-- By Zeba Siddiqui in Mumbai
-- Tue Sep 09, 2014 08:31AM EDT
-- None



MUMBAI, Sept 9 (Reuters) - India's Biocon Ltd <BION.NS> said on Tuesday it agreed to buy a 7.7 percent stake in its research services business from a unit of GE Capital for 2.15 billion rupees ($35.48 million).

Biocon said it would buy the stake in unit Syngene, which is involved in pharmaceutical contract research and manufacturing,  from GE Equity International Mauritius.